These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 18827910)

  • 21. Cardiovascular Disease Risk in Patients with Rheumatic Diseases.
    Mackey RH; Kuller LH; Moreland LW
    Clin Geriatr Med; 2017 Feb; 33(1):105-117. PubMed ID: 27886692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in Children Born to Women with Rheumatic Diseases.
    Vinet É; Bernatsky S
    Rheum Dis Clin North Am; 2017 May; 43(2):263-273. PubMed ID: 28390568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
    Aaramaa HK; Mars N; Helminen M; Kerola AM; Palomäki A; Eklund KK; Gracia-Tabuenca J; Sinisalo J; FinnGen ; Isomäki P
    Semin Arthritis Rheum; 2024 Apr; 65():152382. PubMed ID: 38308930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
    Danninger K; Hoppe UC; Pieringer H
    Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?].
    Fischer-Betz R; Beer S; Schneider M
    Z Rheumatol; 2005 May; 64(4):229-38. PubMed ID: 15909083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammation as a risk factor for atherothrombosis.
    van Leuven SI; Franssen R; Kastelein JJ; Levi M; Stroes ES; Tak PP
    Rheumatology (Oxford); 2008 Jan; 47(1):3-7. PubMed ID: 17702769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
    Fragoulis GE; Panayotidis I; Nikiphorou E
    Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Statins--are they potentially useful in rheumatology?].
    Bielinska A; Gluszko P
    Pol Arch Med Wewn; 2007 Sep; 117(9):420-5. PubMed ID: 18062565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
    Giollo A; Bissell LA; Buch MH
    Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
    Bakshi J; Segura BT; Wincup C; Rahman A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):352-367. PubMed ID: 28853005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
    Chogle AR; Chakravarty A
    J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
    Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
    Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.
    Kahlenberg JM; Kaplan MJ
    Annu Rev Med; 2013; 64():249-63. PubMed ID: 23020882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.
    Boyer JF; Cantagrel A; Constantin A
    Curr Vasc Pharmacol; 2008 Jul; 6(3):218-27. PubMed ID: 18673161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.
    Schoenfeld SR; Kasturi S; Costenbader KH
    Semin Arthritis Rheum; 2013 Aug; 43(1):77-95. PubMed ID: 23422269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins for prevention of cardiovascular disease in systemic lupus erythematosus.
    Yousef Yengej FA; Limper M; Leavis HL
    Neth J Med; 2017 Apr; 75(3):99-105. PubMed ID: 28469051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus.
    Restivo V; Candiloro S; Daidone M; Norrito R; Cataldi M; Minutolo G; Caracci F; Fasano S; Ciccia F; Casuccio A; Tuttolomondo A
    Autoimmun Rev; 2022 Jan; 21(1):102925. PubMed ID: 34454117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
    Gustafsson JT; Svenungsson E
    Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.